Certara, Inc. (CERT)
Health Care / Health Care Technology
S&P SmallCap 600$5.49
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Is Certara, Inc. a Good Investment in 2026?
Certara, Inc. (CERT) scores 2.6 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates Certara, Inc. as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 71%). Certara, Inc. currently trades above its estimated fair value of $3, suggesting limited upside at current prices. Certara, Inc. ranks #1051 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value — the market may be pricing in future growth.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 71%)
Frequently Asked Questions
Is Certara, Inc. (CERT) a good investment?
What is Certara, Inc.'s Piotroski F-Score?
Is CERT overvalued or undervalued?
How does CERT compare to other Health Care stocks?
What do investment models say about CERT?
Similar Stocks
Compare CERT with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer